Carolina Infusion, Llc: Semaglutide 3 Mg/ml Injectable, 8 X 0
Recall Summary Carolina Infusion, LLC is recalling Semaglutide 3 mg/mL Injectable (8 syringes per package) distributed nationwide because the company cannot guarantee the product is sterile due to issues with the bacteriostatic water used in the formulation and the processing equipment. This is a Class II recall affecting customers in all U.S. states and Washington, D.C.
- Recalling firm
- Carolina Infusion, LLC
- Product
- SEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936
- Reason
- Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-10
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the U.S
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/f7dab3a6-d693-486e-a9b3-21bcb37ae5b1